The search for validated biomarkers in the face of biosystems complexity

16 April 2005 , By Professor Ian Humphery-Smith and Will Dracup , Spring 2005
Posted in Archive, Precision Medicine | Tagged Academic, AI / data analytics / healthtech / informatics, Analysis, Analytical chemistry, Assay development optimisation & technology, Automation / robotics, Biochemistry, Biomarkers, Cellular & Molecular biology, Chemical engineering, Chemistry, Clinical trials, Combinatorial chemistry, Computational chemistry, Drug development, Drug discovery, Drug targets, Genetics / genomes, Genetics / genomics, Genomics, High Throughput screening, Imaging, In Silico Biology, Mass spectrometry, Metabolomics, Molecular medicine, Pharmokinetics, Preclinical, Protein chemistry / Proteomics, RNA, Screening, Stem cells, System biology, Systems biology, Target validation, Therapeutics, Translational, Translational chemistry The search for validated biomarkers in the face of biosystems complexity By Professor Ian Humphery-Smith and Will Dracup As the pharmaceutical industry is all too well aware, the genomics and postgenomic sciences have delivered an excessive number of drug targets few of which have been well validated. Indeed, apart from a few rare exceptions, genomics [...]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!